Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolli

Showing results (321-330 of 705) with videos related to

Pageof 71
Sort By:
The Journal of Pathology. Clinical Research|March 6, 2025
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behaviorGiovanna Sabella, Giovanni Centonze, Patrick Maisonneuve, et al.
Histopathology|October 14, 2022
Lung carcinoid tumours: histology and Ki-67, the eternal rivalryGiovanni Centonze, Patrick Maisonneuve, Michele Simbolo, et al.
Endocrine Pathology|October 24, 2025
Digital Immunophenotyping of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Subtypes With Specific Tumor-Immune Microenvironment FeaturesGiovanni Centonze, Patrick Maisonneuve, Émilie Mathian, et al.
Acta Neuropathologica|December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastomaAlfa H C Bai, Till Milde, Marc Remke, et al.
Cancers|March 25, 2022
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled TrialSelinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Neuroendocrinology|May 5, 2020
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct PrognosisMassimo Milione, Patrick Maisonneuve, Federica Grillo, et al.
Cancers|March 11, 2023
Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. <i>Cancers</i> 2022, <i>14</i>, 1510Selinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Virchows Archiv : an International Journal of Pathology|January 3, 2024
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectivesMichele Simbolo, Giovanni Centonze, Anastasios Gkountakos, et al.
The Journal of Experimental Medicine|August 9, 2020
NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammationCarla Noemi Castro, Michelle Rosenzwajg, Raphael Carapito, et al.
Cancers|October 14, 2022
Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic ImplicationsMichele Simbolo, Giovanni Centonze, Luca Giudice, et al.
Pageof 71

Showing results (321-330 of 705) with videos related to

Sort By:
Pageof 71
The Journal of Pathology. Clinical Research|March 6, 2025
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behaviorGiovanna Sabella, Giovanni Centonze, Patrick Maisonneuve, et al.
Histopathology|October 14, 2022
Lung carcinoid tumours: histology and Ki-67, the eternal rivalryGiovanni Centonze, Patrick Maisonneuve, Michele Simbolo, et al.
Endocrine Pathology|October 24, 2025
Digital Immunophenotyping of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Subtypes With Specific Tumor-Immune Microenvironment FeaturesGiovanni Centonze, Patrick Maisonneuve, Émilie Mathian, et al.
Acta Neuropathologica|December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastomaAlfa H C Bai, Till Milde, Marc Remke, et al.
Cancers|March 25, 2022
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled TrialSelinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Neuroendocrinology|May 5, 2020
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct PrognosisMassimo Milione, Patrick Maisonneuve, Federica Grillo, et al.
Cancers|March 11, 2023
Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. <i>Cancers</i> 2022, <i>14</i>, 1510Selinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Virchows Archiv : an International Journal of Pathology|January 3, 2024
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectivesMichele Simbolo, Giovanni Centonze, Anastasios Gkountakos, et al.
The Journal of Experimental Medicine|August 9, 2020
NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammationCarla Noemi Castro, Michelle Rosenzwajg, Raphael Carapito, et al.
Cancers|October 14, 2022
Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic ImplicationsMichele Simbolo, Giovanni Centonze, Luca Giudice, et al.
Pageof 71